Cargando…
Immunomodulatory Protein Hydrolysates and Their Application
Immunomodulatory protein hydrolysate consumption may delay or prevent western immune-related diseases. In order to purposively develop protein hydrolysates with an optimal and reproducible immunomodulatory effect, knowledge is needed on which components in protein hydrolysates are responsible for th...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073538/ https://www.ncbi.nlm.nih.gov/pubmed/30011891 http://dx.doi.org/10.3390/nu10070904 |
_version_ | 1783344213776138240 |
---|---|
author | Kiewiet, Mensiena B. G. Faas, Marijke M. de Vos, Paul |
author_facet | Kiewiet, Mensiena B. G. Faas, Marijke M. de Vos, Paul |
author_sort | Kiewiet, Mensiena B. G. |
collection | PubMed |
description | Immunomodulatory protein hydrolysate consumption may delay or prevent western immune-related diseases. In order to purposively develop protein hydrolysates with an optimal and reproducible immunomodulatory effect, knowledge is needed on which components in protein hydrolysates are responsible for the immune effects. Important advances have been made on this aspect. Also, knowledge on mechanisms underlying the immune modulating effects is indispensable. In this review, we discuss the most promising application possibilities for immunomodulatory protein hydrolysates. In order to do so, an overview is provided on reported in vivo immune effects of protein hydrolysates in both local intestinal and systemic organs, and the current insights in the underlying mechanisms of these effects. Furthermore, we discuss current knowledge and physicochemical approaches to identify the immune active protein sequence(s). We conclude that multiple hydrolysate compositions show specific immune effects. This knowledge can improve the efficacy of existing hydrolysate-containing products such as sports nutrition, clinical nutrition, and infant formula. We also provide arguments for why immunomodulatory protein hydrolysates could be applied to manage the immune response in the increasing number of individuals with a higher risk of immune dysfunction due to, for example, increasing age or stress. |
format | Online Article Text |
id | pubmed-6073538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60735382018-08-13 Immunomodulatory Protein Hydrolysates and Their Application Kiewiet, Mensiena B. G. Faas, Marijke M. de Vos, Paul Nutrients Review Immunomodulatory protein hydrolysate consumption may delay or prevent western immune-related diseases. In order to purposively develop protein hydrolysates with an optimal and reproducible immunomodulatory effect, knowledge is needed on which components in protein hydrolysates are responsible for the immune effects. Important advances have been made on this aspect. Also, knowledge on mechanisms underlying the immune modulating effects is indispensable. In this review, we discuss the most promising application possibilities for immunomodulatory protein hydrolysates. In order to do so, an overview is provided on reported in vivo immune effects of protein hydrolysates in both local intestinal and systemic organs, and the current insights in the underlying mechanisms of these effects. Furthermore, we discuss current knowledge and physicochemical approaches to identify the immune active protein sequence(s). We conclude that multiple hydrolysate compositions show specific immune effects. This knowledge can improve the efficacy of existing hydrolysate-containing products such as sports nutrition, clinical nutrition, and infant formula. We also provide arguments for why immunomodulatory protein hydrolysates could be applied to manage the immune response in the increasing number of individuals with a higher risk of immune dysfunction due to, for example, increasing age or stress. MDPI 2018-07-14 /pmc/articles/PMC6073538/ /pubmed/30011891 http://dx.doi.org/10.3390/nu10070904 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Kiewiet, Mensiena B. G. Faas, Marijke M. de Vos, Paul Immunomodulatory Protein Hydrolysates and Their Application |
title | Immunomodulatory Protein Hydrolysates and Their Application |
title_full | Immunomodulatory Protein Hydrolysates and Their Application |
title_fullStr | Immunomodulatory Protein Hydrolysates and Their Application |
title_full_unstemmed | Immunomodulatory Protein Hydrolysates and Their Application |
title_short | Immunomodulatory Protein Hydrolysates and Their Application |
title_sort | immunomodulatory protein hydrolysates and their application |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073538/ https://www.ncbi.nlm.nih.gov/pubmed/30011891 http://dx.doi.org/10.3390/nu10070904 |
work_keys_str_mv | AT kiewietmensienabg immunomodulatoryproteinhydrolysatesandtheirapplication AT faasmarijkem immunomodulatoryproteinhydrolysatesandtheirapplication AT devospaul immunomodulatoryproteinhydrolysatesandtheirapplication |